Video

Mitigate Risk Of Virus Contaminations In Biopharma Manufacturing

Source: Sartorius
sartorius

Virus contaminations of cell cultures can lead to the closure of biopharmaceutical manufacturing facilities. Franz Nothelfer of Boehringer Ingelheim explains, at the European Upstream & Downstream Forum 2016, why growth media filtration with a virus-retentive filter could become the only risk-mitigation method accepted by the regulatory authorities.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Sartorius